Beyond Air, Inc. Interest Income (Expense), Net
Beyond Air, Inc. (XAIR) reported Interest Income (Expense), Net of -$2.05 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2018-11-14
- Beyond Air, Inc. interest income (expense), net for the quarter ending 2018-09-30 was -$2.05M.
- Beyond Air, Inc. interest income (expense), net for the quarter ending 2018-06-30 was -$1.25M, a 765.78% decline year-over-year.
- Beyond Air, Inc. interest income (expense), net for the quarter ending 2018-03-31 was -$3.49M, a 228.38% decline year-over-year.
- Beyond Air, Inc. interest income (expense), net for the quarter ending 2017-09-30 was -$5.09M.
- Beyond Air, Inc. interest income (expense), net for fiscal 2017 was $6.98M, a 413.01% increase from fiscal 2016.
- Beyond Air, Inc. interest income (expense), net for fiscal 2016 was $1.36M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|
| 2018-09-30 | -$2.05M 10-Q · filed 2018-11-14 | -$3.29M 10-Q · filed 2018-11-14 | -$6.78M derived: sum of 3 quarters · filed 2018-11-14 | ||
| 2018-06-30 | -$1.25M 10-Q · filed 2018-08-14 | -$4.73M derived: sum of 2 quarters · filed 2018-08-14 | |||
| 2018-03-31 | -$3.49M 10-KT · filed 2018-06-15 | ||||
| 2017-12-31 | $6.98M 10-KT · filed 2018-06-15 | -$6.98M 10-K · filed 2018-03-30 | |||
| 2017-09-30 | -$5.09M 10-Q · filed 2018-11-14 | -$4.91M 10-Q · filed 2018-11-14 | -$2.19M derived: sum of 3 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $187.00K 10-Q · filed 2018-08-14 | $2.90M derived: sum of 2 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $2.72M 10-KT · filed 2018-06-15 | ||||
| 2016-12-31 | $1.36M 10-KT · filed 2018-06-15 | -$1.36M 10-K · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |